Table of Contents
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased database
1.4.2 GVR’s internal database
1.4.3 Secondary sources
1.4.4 Primary research
1.4.5 Details of primary research
1.5 Information or Data Analysis
1.5.1 Data analysis models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity flow analysis
1.7.1.1 Approach 1: Commodity flow approach
1.7.1.2 Approach 2: Country wise market estimation using bottom up approach
1.8 Global Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
1.12 List of Tables
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Regulatory and Reimbursement Framework
3.2 Market Variable Analysis
3.2.1 Increasing incidence of cancer
3.2.2 Rising prevalence of metabolic disorders
3.2.3 Presence of strong product pipeline
3.2.4 Technological advancement
3.3 Market Restraint Analysis
3.3.1 Increasing complexity of peptides
3.3.2 High cost of manufacturing equipment
3.4 Penetration and Growth Prospect Mapping
3.5 Peptide Therapeutics Market Analysis Tools
3.5.1 Porter’s five forces analysis
3.5.2 SWOT analysis; by factor (Political & Legal, Economic and Technological)
3.5.3 Major deals & strategic alliances analysis
3.5.3.1 New product launch
3.5.3.2 Mergers and acquisitions
3.5.3.3 Expansion
3.5.3.4 Partnerships
3.5.3.5 Marketing & promotions
3.5.3.6 Market entry strategies
Chapter 4 Application Movement Analysis
4.1 Peptide Therapeutics Market: Application Movement Analysis
4.2 Cancer
4.2.1 Cancer market estimates and forecast, 2018 – 2030 (USD Billion)
4.3 Metabolic Disorders
4.3.1 Metabolic disorders market estimates and forecast, 2018 – 2030 (USD Billion)
4.4 Cardiovascular Disorders
4.4.1 Cardiovascular disorders market estimates and forecast, 2018 – 2030 (USD Billion)
4.5 Dermatological Disorders
4.5.1 Dermatological disorders market estimates and forecast, 2018 – 2030 (USD Billion)
4.6 Infectious Diseases
4.6.1 Infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
4.7 Neurological Disorders
4.7.1 Neurological disorders market estimates and forecast, 2018 – 2030 (USD Billion)
4.8 Gastrointestinal Disorders
4.8.1 Gastrointestinal disorders market estimates and forecast, 2018 – 2030 (USD Billion)
4.9 Renal Disorders
4.9.1 Renal disorders market estimates and forecast, 2018 – 2030 (USD Billion)
4.10 Respiratory Disorders
4.10.1 Respiratory disorders market estimates and forecast, 2018 – 2030 (USD Billion)
4.11 Pain
4.11.1 Pain market estimates and forecast, 2018 – 2030 (USD Billion)
4.12 Others
4.12.1 Others market estimates and forecast, 2018 – 2030 (USD Billion)
Chapter 5 Type Movement Analysis
5.1 Peptide therapeutics Market: Type Movement Analysis
5.2 Generic
5.2.1 Generic market estimates and forecast, 2018 – 2030 (USD Billion)
5.3 Innovative
5.3.1 Innovative market estimates and forecast, 2018 – 2030 (USD Billion)
Chapter 6 Type of Manufacturers Movement Analysis
6.1 Peptide Therapeutics Market: Type of Manufacturers Movement Analysis
6.2 In-house
6.2.1 In-house market estimates and forecast, 2018 – 2030 (USD Billion)
6.3 Outsourced
6.3.1 Outsourced market estimates and forecast, 2018 – 2030 (USD Billion)
Chapter 7 Route of Administration Movement Analysis
7.1 Peptide Therapeutics Market: Route of Administration Movement Analysis
7.2 Parenteral
7.2.1 Parenteral market estimates and forecast, 2018 – 2030 (USD Billion)
7.3 Oral
7.3.1 Oral market estimates and forecast, 2018 – 2030 (USD Billion)
7.4 Pulmonary
7.4.1 Pulmonary market estimates and forecast, 2018 – 2030 (USD Billion)
7.5 Mucosal
7.5.1 Mucosal market estimates and forecast, 2018 – 2030 (USD Billion)
7.6 Others
7.6.1 Others market estimates and forecast, 2018 – 2030 (USD Billion)
Chapter 8 Synthesis Technology Movement Analysis
8.1 Peptide Therapeutics Market: Synthesis Technology Movement Analysis
8.2 Solid Phase Peptide Synthesis (SPPS)
8.2.1 SPPS market estimates and forecast, 2018 – 2030 (USD Billion)
8.3 Liquid Phase Peptide Synthesis (LPPS)
8.3.1 LPPS market estimates and forecast, 2018 – 2030 (USD Billion)
8.4 Hybrid
8.4.1 Hybrid market estimates and forecast, 2018 – 2030 (USD Billion)
Chapter 9 Regional Business Analysis
9.1 Peptide Therapeutics Market: Regional Outlook
9.2 North America
9.2.1 North America Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
9.2.2 U.S.
9.2.2.1 Key Country Dynamics
9.2.2.2 U.S. Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.2.2.3 Target Disease Prevalence
9.2.2.5 Competitive Scenario
9.2.2.6 Regulatory Framework
9.2.2.7 Reimbursement Scenario
9.2.3 Canada
9.2.3.1 Key Country Dynamics
9.2.3.2 Canada Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.2.3.3 Target Disease Prevalence
9.2.3.4 Competitive Scenario
9.2.3.5 Regulatory Framework
9.2.3.6 Reimbursement Scenario
9.3 Europe
9.3.1 Europe Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
9.3.2 U.K.
9.3.2.1 Key Country Dynamics
9.3.2.2 U.K. Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.2.3 Target Disease Prevalence
9.3.2.4 Competitive Scenario
9.3.2.5 Regulatory Framework
9.3.2.6 Reimbursement Scenario
9.3.3 Germany
9.3.3.1 Key Country Dynamics
9.3.3.2 Germany Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.3.3 Target Disease Prevalence
9.3.3.4 Competitive Scenario
9.3.3.5 Regulatory Framework
9.3.3.6 Reimbursement Scenario
9.3.4 France
9.3.4.1 Key Country Dynamics
9.3.4.2 France Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.4.3 Target Disease Prevalence
9.3.4.4 Competitive Scenario
9.3.4.5 Regulatory Framework
9.3.4.6 Reimbursement Scenario
9.3.5 Italy
9.3.5.1 Key Country Dynamics
9.3.5.2 Italy Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.5.3 Target Disease Prevalence
9.3.5.4 Competitive Scenario
9.3.5.5 Regulatory Framework
9.3.5.6 Reimbursement Scenario
9.3.6 Spain
9.3.6.1 Key Country Dynamics
9.3.6.2 Spain Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.6.3 Target Disease Prevalence
9.3.6.4 Competitive Scenario
9.3.6.5 Regulatory Framework
9.3.6.6 Reimbursement Scenario
9.3.7 Denmark
9.3.9.1 Key Country Dynamics
9.3.9.2 Denmark Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.9.3 Target Disease Prevalence
9.3.9.4 Competitive Scenario
9.3.9.5 Regulatory Framework
9.3.9.6 Reimbursement Scenario
9.3.8 Sweden
9.3.8.1 Key Country Dynamics
9.3.8.2 Sweden Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.8.3 Target Disease Prevalence
9.3.8.4 Competitive Scenario
9.3.8.5 Regulatory Framework
9.3.8.6 Reimbursement Scenario
9.3.9 Norway
9.3.9.1 Key Country Dynamics
9.3.9.2 Norway Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.9.3 Target Disease Prevalence
9.3.9.4 Competitive Scenario
9.3.9.5 Regulatory Framework
9.3.9.6 Reimbursement Scenario
9.4 Asia Pacific
9.4.1 Asia Pacific Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
9.4.2 Japan
9.4.2.1 Key Country Dynamics
9.4.2.2 Japan Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.4.2.3 Target Disease Prevalence
9.4.2.4 Competitive Scenario
9.4.2.5 Regulatory Framework
9.4.2.6 Reimbursement Scenario
9.4.3 China
9.4.3.1 Key Country Dynamics
9.4.3.2 China Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.4.3.3 Target Disease Prevalence
9.4.3.4 Competitive Scenario
9.4.3.5 Regulatory Framework
9.4.3.6 Reimbursement Scenario
9.4.4 India
9.4.4.1 Key Country Dynamics
9.4.4.2 India Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.4.4.3 Target Disease Prevalence
9.4.4.4 Competitive Scenario
9.4.4.5 Regulatory Framework
9.4.4.6 Reimbursement Scenario
9.4.5 Australia
9.4.5.1 Key Country Dynamics
9.4.5.2 Australia Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.4.5.3 Target Disease Prevalence
9.4.5.4 Competitive Scenario
9.4.5.5 Regulatory Framework
9.4.5.6 Reimbursement Scenario
9.4.6 South Korea
9.4.6.1 Key Country Dynamics
9.4.6.2 South Korea Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.4.6.3 Target Disease Prevalence
9.4.6.4 Competitive Scenario
9.4.6.5 Regulatory Framework
9.4.6.6 Reimbursement Scenario
9.4.7 Thailand
9.4.7.1 Key Country Dynamics
9.4.7.2 Thailand Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.4.7.3 Target Disease Prevalence
9.4.7.4 Competitive Scenario
9.4.7.5 Regulatory Framework
9.4.7.6 Reimbursement Scenario
9.5 Latin America
9.5.1 Latin America Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
9.5.2 Brazil
9.5.2.1 Key Country Dynamics
9.5.2.2 Brazil Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.5.2.3 Target Disease Prevalence
9.5.2.4 Competitive Scenario
9.5.2.5 Regulatory Framework
9.5.2.6 Reimbursement Scenario
9.5.3 Mexico
9.5.3.1 Key Country Dynamics
9.5.3.2 Mexico Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.5.3.3 Target Disease Prevalence
9.5.3.4 Competitive Scenario
9.5.3.5 Regulatory Framework
9.5.3.6 Reimbursement Scenario
9.5.4 Argentina
9.5.4.1 Key Country Dynamics
9.5.4.2 Argentina Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.5.4.3 Target Disease Prevalence
9.5.4.4 Competitive Scenario
9.5.4.5 Regulatory Framework
9.5.4.6 Reimbursement Scenario
9.5.4 Chile
9.5.5.1 Key Country Dynamics
9.5.5.2 Chile Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.5.5.3 Target Disease Prevalence
9.5.5.4 Competitive Scenario
9.5.5.5 Regulatory Framework
9.5.5.6 Reimbursement Scenario
9.6 Middle East and Africa
9.6.1 Middle East and Africa Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
9.6.1.1 Target Disease Prevalence
9.6.1.2 Competitive Scenario
9.6.1.3 Regulatory Framework
9.6.1.4 Reimbursement Scenario
9.6.2 South Africa
9.6.2.1 Key Country Dynamics
9.6.2.2 South Africa Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.6.2.3 Target Disease Prevalence
9.6.2.4 Competitive Scenario
9.6.2.5 Regulatory Framework
9.6.2.6 Reimbursement Scenario
9.6.3 Saudi Arabia
9.6.3.1 Key Country Dynamics
9.6.3.2 Saudi Arabia Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.6.3.3 Target Disease Prevalence
9.6.3.4 Competitive Scenario
9.6.3.5 Regulatory Framework
9.6.3.6 Reimbursement Scenario
9.6.4 UAE
9.6.4.1 Key Country Dynamics
9.6.4.2 UAE Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.6.4.3 Target Disease Prevalence
9.6.4.4 Competitive Scenario
9.6.4.5 Regulatory Framework
9.6.4.6 Reimbursement Scenario
9.6.5 Kuwait
9.6.5.1 Key Country Dynamics
9.6.5.2 Kuwait Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.6.5.3 Target Disease Prevalence
9.6.5.4 Competitive Scenario
9.6.5.5 Regulatory Framework
9.6.5.6 Reimbursement Scenario
Chapter 10 Competitive Landscape
10.1 Company Categorization
10.2 Strategy Mapping
10.2.1 New Product Launch
10.2.2 Partnerships
10.2.3 Acquisition
10.2.4 Collaboration
10.2.5 Funding
10.3 Key Company Market Share Analysis, 2022
10.4 Company Profiles
10.4.1 Eli Lilly and Company
10.4.1.1 Company Overview
10.4.1.2 Financial Performance
10.4.1.3 Product Benchmarking
10.4.1.4 Strategic Initiatives
10.4.2 Pfizer, Inc.
10.4.2.1 Company Overview
10.4.2.2 Financial Performance
10.4.2.3 Product Benchmarking
10.4.2.4 Strategic Initiatives
10.4.3 Amgen, Inc.
10.4.3.1 Company Overview
10.4.3.2 Financial Performance
10.4.3.3 Product Benchmarking
10.4.3.4 Strategic Initiatives
10.4.4 Takeda Pharmaceutical Company Limited
10.4.4.1 Company Overview
10.4.4.2 Financial Performance
10.4.4.3 Product Benchmarking
10.4.4.4 Strategic Initiatives
10.4.5 AstraZeneca
10.4.5.1 Company Overview
10.4.5.2 Financial Performance
10.4.5.3 Product Benchmarking
10.4.5.4 Strategic Initiatives
10.4.6 Teva Pharmaceutical Industries Ltd.
10.4.6.1 Company Overview
10.4.6.2 Financial Performance
10.4.6.3 Product Benchmarking
10.4.6.4 Strategic Initiatives
10.4.7 Sanofi
10.4.7.1 Company Overview
10.4.7.2 Financial Performance
10.4.7.3 Product Benchmarking
10.4.7.4 Strategic Initiatives
10.4.8 F. Hoffmann-La Roche Ltd
10.4.8.1 Company Overview
10.4.8.2 Financial Performance
10.4.8.3 Product Benchmarking
10.4.8.4 Strategic Initiatives
10.4.9 Novartis AG
10.4.9.1 Company Overview
10.4.9.2 Financial Performance
10.4.9.3 Product Benchmarking
10.4.9.4 Strategic Initiatives
10.4.10 Novo Nordisk A/S
10.4.10.1 Company Overview
10.4.10.2 Financial Performance
10.4.10.3 Product Benchmarking
10.4.10.4 Strategic Initiatives
10.4.11 GSK plc
10.4.11.1 Company Overview
10.4.11.2 Financial Performance
10.4.11.3 Product Benchmarking
10.4.11.4 Strategic Initiatives
10.4.12 Ironwood Pharmaceuticals, Inc.
10.4.12.1 Company Overview
10.4.12.2 Financial Performance
10.4.12.3 Product Benchmarking
10.4.12.4 Strategic Initiatives
10.4.13 Radius Health, Inc.
10.4.13.1 Company Overview
10.4.13.2 Financial Performance
10.4.13.3 Product Benchmarking
10.4.13.4 Strategic Initiatives
10.4.14 Ipsen Pharma
10.4.14.1 Company Overview
10.4.14.2 Financial Performance
10.4.14.3 Product Benchmarking
10.4.14.4 Strategic Initiatives
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 4 North America peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 5 North America peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 6 North America peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 7 North America peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 8 North America peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 9 U.S. peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 10 U.S. peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 11 U.S. peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 12 U.S. peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 13 U.S. peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 14 Canada peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 15 Canada peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 16 Canada peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 17 Canada peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 18 Canada peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 19 Europe peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 20 Europe peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 21 Europe peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 22 Europe peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 23 Europe peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 24 Europe peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 25 UK peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 26 UK peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 27 UK peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 28 UK peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 29 UK peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 30 Germany peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 31 Germany peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 32 Germany peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 33 Germany peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 34 Germany peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 35 France peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 36 France peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 37 France peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 38 France peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 39 France peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 40 Spain peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 41 Spain peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 42 Spain peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 43 Spain peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 44 Spain peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 45 Italy peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 46 Italy peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 47 Italy peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 48 Italy peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 49 Italy peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 49 Denmark peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 50 Denmark peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 51 Denmark peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 52 Denmark peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 53 Denmark peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 54 Sweden peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 55 Sweden peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 56 Sweden peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 57 Sweden peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 58 Sweden peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 59 Norway peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 60 Norway peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 61 Norway peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 62 Norway peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 63 Norway peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 64 Asia Pacific peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 65 Asia Pacific peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 66 Asia Pacific peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 67 Asia Pacific peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 68 Asia Pacific peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 69 Asia Pacific peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 70 Japan peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 71 Japan peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 72 Japan peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 73 Japan peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 74 Japan peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 75 China peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 76 China peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 77 China peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 78 China peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 79 China peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 80 India peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 81 India peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 82 India peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 83 India peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 84 India peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 85 South Korea peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 86 South Korea peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 87 South Korea peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 88 South Korea peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 89 South Korea peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 90 Australia peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 91 Australia peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 92 Australia peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 93 Australia peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 94 Australia peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 95 Thailand peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 96 Thailand peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 97 Thailand peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 98 Thailand peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 99 Thailand peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 100 Latin America peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 102 Latin America peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 102 Latin America peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 103 Latin America peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 104 Latin America peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 105 Latin America peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 106 Brazil peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 107 Brazil peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 108 Brazil peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 109 Brazil peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 110 Brazil peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 111 Mexico peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 112 Mexico peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 113 Mexico peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 114 Mexico peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 115 Mexico peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 116 Argentina peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 117 Argentina peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 118 Argentina peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 119 Argentina peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 120 Argentina peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 121 Chile peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 122 Chile peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 123 Chile peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 124 Chile peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 125 Chile peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 126 MEA peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 127 MEA peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 128 MEA peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 129 MEA peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 130 MEA peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 131 MEA peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 132 South Africa peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 133 South Africa peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 134 South Africa peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 135 South Africa peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 136 South Africa peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 137 UAE peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 138 UAE peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 139 UAE peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 140 UAE peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 141 UAE peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 142 Saudi Arabia peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 143 Saudi Arabia peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 144 Saudi Arabia peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 145 Saudi Arabia peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 146 Saudi Arabia peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 147 Kuwait peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 148 Kuwait peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 149 Kuwait peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 150 Kuwait peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 151 Kuwait peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)